Provenance Wealth Advisors’s HCA Healthcare HCA Stock Holding History

Provenance Wealth Advisors’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.9K	Buy	+10	New	+$4.23K	﹤0.01%	406

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Provenance Wealth Advisors's HCA Position: Q2 2026 in Review

Provenance Wealth Advisors opened a new position in HCA Healthcare (HCA) in Q2 2026: 10 shares worth $3.9K. The stake represents ﹤0.01% of the portfolio and ranks #406 among its holdings.

1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Provenance Wealth Advisors held 10 shares of HCA Healthcare worth $3.9K as of Q2 2026.
HCA Healthcare was a new Provenance Wealth Advisors position in Q2 2026.
HCA Healthcare made up ﹤0.01% of Provenance Wealth Advisors's portfolio in Q2 2026, its #406 holding.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.